TGEN http://www.tgen.org/news/index.cfm?pageid=842 Dr. Daniel Von Hoff leads the Clinical Translational Research Division at TGen which focuses on genetic and biochemical approaches to identify diagnostics and molecular targets for the development of new therapies for pancreatic cancer. Dr. Daniel Von Hoff leads the Clinical Translational Research Division at TGen which focuses on genetic and biochemical approaches to identify diagnostics and molecular targets for the development of new therapies for pancreatic cancer. no Genomics Research en-us Copyright TGen 2008 Thu, 20 Nov 2008 16:23:00 PST http://public.tgen.org/tgen.org/downloads/podcast/PANCREATICVIDEO_TSa.mp4 news@tgen.org Dr. Daniel Von Hoff leads the Clinical Translational Research Division at TGen which focuses on genetic and biochemical approaches to identify diagnostics and molecular targets for the development of new therapies for pancreatic cancer. Thu, 20 Nov 2008 16:23:00 PST 00:03:05